- Datum24.04.2024
- UhrzeitLäuft gerade
- VeranstalterXTB
Du willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnenHalozyme Therapeutics Inc. Kurse
Passende Produkte
WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
---|
Wertentwicklung (Nasdaq)
Wikifolio
Passender Service zu Halozyme Therapeutics Inc.
Webinar zu Halozyme Therapeutics Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)29,850-45,000
- Jahrestief / Hoch ($)33,150-42,640
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Halozyme Therapeutics Inc.
Termine von Halozyme Therapeutics Inc.
- Mai7Halozyme Therapeutics Inc.Q1 2024 Earnings Release
- Aug6Halozyme Therapeutics Inc.Q2 2024 Earnings Release
- Nov4Halozyme Therapeutics Inc.Q3 2024 Earnings Release
Beschreibung
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.